In the WHAT HEALTH !? newsletter, find the latest news that has made the buzz, cutting-edge trends and groundbreaking innovations in the digital health field.
In today’s newsletter :
Neuralink, a startup funded in 2016 by Elon Musk, has progressed from animal testing to implanting its innovative ‘Telepathy’ chip in a human patient.
This leap towards blending technology with human cognition is not an isolated endeavour; companies like Onward in the Netherlands and research initiatives at CHUV in Lausanne have previously embarked on similar quests, aiming to restore mobility and control to patients with severe physical impairments.
While Neuralink’s ambitions extend to groundbreaking applications such as restoring sight and treating psychiatric conditions, scepticism remains regarding the scientific foundation of these promises.
With a six-year study approved by U.S. regulators, Neuralink’s journey is just beginning, promising a future where integrating technology and biology could redefine human capabilities
>> Find all the latest news in the columns of your weekly
Stay updated on all things in one place!
>> Subscribe here
See you next Thursday!
Your Swiss Digital Health team